» Articles » PMID: 10452968

Cutting Edge: CXCR4-Lo: Molecular Cloning and Functional Expression of a Novel Human CXCR4 Splice Variant

Overview
Journal J Immunol
Date 1999 Aug 24
PMID 10452968
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Human CXCR4 is a specific receptor for the CXC chemokine stromal cell-derived factor-1 (SDF-1) and a coreceptor for T cell line tropic strains of HIV-1. Genetic knockouts of CXCR4 and SDF-1 have delineated their critical role during embryonic cardiogenesis, leukopoiesis, and vasculogenesis. Herein, we used bioinformatics and differential strategies like isoform-specific RT-PCR and Northern blots to identify and clone a novel unspliced isoform of human CXCR4, termed CXCR4-Lo. CXCR4-Lo corresponds to a larger approximately 4. 0-kb mRNA transcript and differs from the known human CXCR4 by the first 9 aa in the functionally important NH2-terminal extracellular domain of the receptor. CXCR4-Lo-transfected rat basophil leukemia-2H3 cells responded to SDF-1 with a transient rise of intracellular Ca2+ concentration and by undergoing chemotaxis. Expression of CXCR4-Lo is noteworthy, as it may have differential affinity as a coreceptor for HIV strains in comparison with CXCR4. Furthermore, CXCR4-Lo may also provide a functional backup to CXCR4 during embryogenesis.

Citing Articles

New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine.

Xu H, Lin S, Zhou Z, Li D, Zhang X, Yu M Cell Mol Immunol. 2023; 20(7):739-776.

PMID: 37198402 PMC: 10189238. DOI: 10.1038/s41423-023-01032-x.


The N-terminus of CXCR4 splice variants determines expression and functional properties.

Park H, Nguyen L, Nguyen T, Cho M, Nguyen H, Hurh S PLoS One. 2023; 18(5):e0283015.

PMID: 37141381 PMC: 10159351. DOI: 10.1371/journal.pone.0283015.


The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B.

DUonnolo G, Reynders N, Meyrath M, Abboud D, Uchanski T, Laeremans T Front Immunol. 2022; 13:868579.

PMID: 35720349 PMC: 9198273. DOI: 10.3389/fimmu.2022.868579.


Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells.

Omer-Javed A, Pedrazzani G, Albano L, Ghaus S, Latroche C, Manzi M Cell. 2022; 185(13):2248-2264.e21.

PMID: 35617958 PMC: 9240327. DOI: 10.1016/j.cell.2022.04.039.


Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editing.

Knipping F, Newby G, Eide C, McElroy A, Nielsen S, Smith K Mol Ther. 2021; 30(1):130-144.

PMID: 34737067 PMC: 8753564. DOI: 10.1016/j.ymthe.2021.10.026.